149 related articles for article (PubMed ID: 33713237)
1. Postnatal Pluripotent Cells: Quarter of a Century of Research.
Yarygina NK; Yarygin KN
Bull Exp Biol Med; 2021 Feb; 170(4):515-521. PubMed ID: 33713237
[TBL] [Abstract][Full Text] [Related]
2. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
[TBL] [Abstract][Full Text] [Related]
3. Chemically Defined Neural Conversion of Human Pluripotent Stem Cells.
Chen Y; Tristan CA; Mallanna SK; Ormanoglu P; Titus S; Simeonov A; Singeç I
Methods Mol Biol; 2019; 1919():59-72. PubMed ID: 30656621
[TBL] [Abstract][Full Text] [Related]
4. Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system.
Xu J; Yu L; Guo J; Xiang J; Zheng Z; Gao D; Shi B; Hao H; Jiao D; Zhong L; Wang Y; Wu J; Wei H; Han J
Stem Cell Res Ther; 2019 Jun; 10(1):193. PubMed ID: 31248457
[TBL] [Abstract][Full Text] [Related]
5. Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration.
Speicher AM; Wiendl H; Meuth SG; Pawlowski M
Mol Neurodegener; 2019 Dec; 14(1):46. PubMed ID: 31856864
[TBL] [Abstract][Full Text] [Related]
6. Characterization of companion animal pluripotent stem cells.
Paterson YZ; Kafarnik C; Guest DJ
Cytometry A; 2018 Jan; 93(1):137-148. PubMed ID: 28678404
[TBL] [Abstract][Full Text] [Related]
7. miRNA-1 and miRNA-133a are involved in early commitment of pluripotent stem cells and demonstrate antagonistic roles in the regulation of cardiac differentiation.
Izarra A; Moscoso I; Cañón S; Carreiro C; Fondevila D; Martín-Caballero J; Blanca V; Valiente I; Díez-Juan A; Bernad A
J Tissue Eng Regen Med; 2017 Mar; 11(3):787-799. PubMed ID: 25492026
[TBL] [Abstract][Full Text] [Related]
8. Vascular research using human pluripotent stem cells and humoral factors.
Sone M; Nakao K
Endocr J; 2013; 60(4):397-402. PubMed ID: 23363929
[TBL] [Abstract][Full Text] [Related]
9. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.
Jiang J; Ding G; Lin J; Zhang M; Shi L; Lv W; Yang H; Xiao H; Pei G; Li Y; Wu J; Li J
J Mol Cell Biol; 2011 Jun; 3(3):197-9. PubMed ID: 21624975
[No Abstract] [Full Text] [Related]
10. [Establishment of an internal control for directed differentiation using pluripotent stem cell lines derived from heterozygotic twins].
Luo YM; Fan Y; Chen XJ; Yue L; Li Q; He WZ; Ma XY; Zheng YH; Sun XF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):398-403. PubMed ID: 22875494
[TBL] [Abstract][Full Text] [Related]
11. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues.
Hanna JH; Saha K; Jaenisch R
Cell; 2010 Nov; 143(4):508-25. PubMed ID: 21074044
[TBL] [Abstract][Full Text] [Related]
12. Important precautions when deriving patient-specific neural elements from pluripotent cells.
Parsons XH; Teng YD; Snyder EY
Cytotherapy; 2009; 11(7):815-24. PubMed ID: 19903095
[TBL] [Abstract][Full Text] [Related]
13. Roles of TGF-β family signals in the fate determination of pluripotent stem cells.
Itoh F; Watabe T; Miyazono K
Semin Cell Dev Biol; 2014 Aug; 32():98-106. PubMed ID: 24910449
[TBL] [Abstract][Full Text] [Related]
14. 3,2'-Dihydroxyflavone-Treated Pluripotent Stem Cells Show Enhanced Proliferation, Pluripotency Marker Expression, and Neuroprotective Properties.
Han D; Kim HJ; Choi HY; Kim B; Yang G; Han J; Dayem AA; Lee HR; Kim JH; Lee KM; Jeong KS; Do SH; Cho SG
Cell Transplant; 2015; 24(8):1511-32. PubMed ID: 25198120
[TBL] [Abstract][Full Text] [Related]
15. Motor neuron differentiation from pluripotent stem cells and other intermediate proliferative precursors that can be discriminated by lineage specific reporters.
Jha BS; Rao M; Malik N
Stem Cell Rev Rep; 2015 Feb; 11(1):194-204. PubMed ID: 25091426
[TBL] [Abstract][Full Text] [Related]
16. A method to identify and isolate pluripotent human stem cells and mouse epiblast stem cells using lipid body-associated retinyl ester fluorescence.
Muthusamy T; Mukherjee O; Menon R; Megha PB; Panicker MM
Stem Cell Reports; 2014 Jul; 3(1):169-84. PubMed ID: 25068130
[TBL] [Abstract][Full Text] [Related]
17. Genome integrity: linking pluripotency and tumorgenicity.
Deng W; Xu Y
Trends Genet; 2009 Oct; 25(10):425-7. PubMed ID: 19801173
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states.
Neveu P; Kye MJ; Qi S; Buchholz DE; Clegg DO; Sahin M; Park IH; Kim KS; Daley GQ; Kornblum HI; Shraiman BI; Kosik KS
Cell Stem Cell; 2010 Dec; 7(6):671-81. PubMed ID: 21112562
[TBL] [Abstract][Full Text] [Related]
19. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
Abraham S; Sheridan SD; Miller B; Rao RR
Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
[TBL] [Abstract][Full Text] [Related]
20. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
